HHS eyeing over $1B from J&J for talc cancer treatments: govt. attorney

An attorney representing the U.S. Department of Health & Human Services (HHS) said on Friday that the agency will ask Johnson & Johnson (NYSE:JNJ) to reimburse more than $1B for treating cancer cases linked to the company’s talc-based products.

Its